Indication: 1.Haemorrhage or risk of haemorrhage in increased fibrinolysis or fibrinogenolysis like: Prostatectomy and bladder surgery, Menorrhagia, Epistaxis, Conisation of the cervix, Management of dental extraction in patients with coagulopathies,Ulcerative colitis, Haematuria,Gastrointestinal ha..
Indication: 1.Haemorrhage or risk of haemorrhage in increased fibrinolysis or fibrinogenolysis like: Prostatectomy and bladder surgery, Menorrhagia, Epistaxis, Conisation of the cervix, Management of dental extraction in patients with coagulopathies,Ulcerative colitis, Haematuria,Gastrointestinal ha..
Intrax CapDescriptionTranexamic acid has a strong inhibitory effect on the activation of plasminogen, i.e. the conversion of plasminogen to plasmin, in the fibrinolytic system. The half-life is 1-2 hours. Plasma protein binding is 3% at therapeutic levels. The plasma protein binding seems fully acco..
IntraxDescriptionTranexamic acid has a strong inhibitory effect on the activation of plasminogen, i.e. the conversion of plasminogen to plasmin, in the fibrinolytic system. The half-life is 1-2 hours. Plasma protein binding is 3% at therapeutic levels. The plasma protein binding seems fully accounte..